449 related articles for article (PubMed ID: 11984005)
1. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a developmentally regulated N-acetylgalactosamine alpha2,6-sialyltransferase specific for sialylated glycoconjugates.
Sjoberg ER; Kitagawa H; Glushka J; van Halbeek H; Paulson JC
J Biol Chem; 1996 Mar; 271(13):7450-9. PubMed ID: 8631773
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.
Harduin-Lepers A; Stokes DC; Steelant WF; Samyn-Petit B; Krzewinski-Recchi MA; Vallejo-Ruiz V; Zanetta JP; Augé C; Delannoy P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):37-48. PubMed ID: 11062056
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens.
Ikehara Y; Kojima N; Kurosawa N; Kudo T; Kono M; Nishihara S; Issiki S; Morozumi K; Itzkowitz S; Tsuda T; Nishimura SI; Tsuji S; Narimatsu H
Glycobiology; 1999 Nov; 9(11):1213-24. PubMed ID: 10536037
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and expression of a human hST8Sia VI (alpha2,8-sialyltransferase) responsible for the synthesis of the diSia motif on O-glycosylproteins.
Teintenier-Lelièvre M; Julien S; Juliant S; Guerardel Y; Duonor-Cérutti M; Delannoy P; Harduin-Lepers A
Biochem J; 2005 Dec; 392(Pt 3):665-74. PubMed ID: 16120058
[TBL] [Abstract][Full Text] [Related]
7. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of Gal beta 1,3GalNAc-specific GalNAc alpha 2,6-sialyltransferase.
Kurosawa N; Kojima N; Inoue M; Hamamoto T; Tsuji S
J Biol Chem; 1994 Jul; 269(29):19048-53. PubMed ID: 8034663
[TBL] [Abstract][Full Text] [Related]
9. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
10. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
[TBL] [Abstract][Full Text] [Related]
11. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups.
Kitagawa H; Paulson JC
J Biol Chem; 1994 Jan; 269(2):1394-401. PubMed ID: 8288606
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line.
Giordanengo V; Bannwarth S; Laffont C; Van Miegem V; Harduin-Lepers A; Delannoy P; Lefebvre JC
Eur J Biochem; 1997 Jul; 247(2):558-66. PubMed ID: 9266697
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells.
Samyn-Petit B; Krzewinski-Recchi MA; Steelant WF; Delannoy P; Harduin-Lepers A
Biochim Biophys Acta; 2000 Apr; 1474(2):201-11. PubMed ID: 10742600
[TBL] [Abstract][Full Text] [Related]
14. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and expression of a sixth type of alpha 2,8-sialyltransferase (ST8Sia VI) that sialylates O-glycans.
Takashima S; Ishida HK; Inazu T; Ando T; Ishida H; Kiso M; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Jul; 277(27):24030-8. PubMed ID: 11980897
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and genomic analysis of mouse Galbeta1, 3GalNAc-specific GalNAc alpha2,6-sialyltransferase.
Kurosawa N; Inoue M; Yoshida Y; Tsuji S
J Biol Chem; 1996 Jun; 271(25):15109-16. PubMed ID: 8662927
[TBL] [Abstract][Full Text] [Related]
17. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of cDNA for a new type of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase.
Lee YC; Kojima N; Wada E; Kurosawa N; Nakaoka T; Hamamoto T; Tsuji S
J Biol Chem; 1994 Apr; 269(13):10028-33. PubMed ID: 8144500
[TBL] [Abstract][Full Text] [Related]
19. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
